Japan Lifeline Co Ltd
TSE:7575
Japan Lifeline Co Ltd
TSE:7575
Price:
1 177 JPY
-1.34%
Updated:
May 15, 2024
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT
7.3
Current
7.2
Median
17.8
Industry
Higher
than median
Lower
than industry value
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
EV/EBIT
=7.3
Enterprise Value
/
81.9B
EBIT
11.4B
All Countries
| Market Cap | EV/EBIT | ||||
|---|---|---|---|---|---|
| JP |
|
Japan Lifeline Co Ltd
TSE:7575
|
88.7B JPY | 7.3 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.9B USD | 28.3 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
136.3B USD | 70.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
123.5B USD | 29.4 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
112.1B USD | 20 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
108B USD | 45.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.9B USD | 39.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 31.5 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
378.2B CNY | 28.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 28.9 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
49.9B USD | 76 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/EBIT
N/A
2-Years Forward
EV/EBIT
N/A
3-Years Forward
EV/EBIT
N/A
You don't have any saved screeners yet
